Rituxan

FDA Approves Genentech’s Rituxan For Rare Autoimmune Disease Pemphigus Vulgaris
CP Wire
Fri, 06/8/18 - 10:07 am
Genentech
Rituxan
FDA
pemphigus vulgaris
Genentech/Roche
FDA Approves Genentech’s Rituxan For Rare Autoimmune Disease Pemphigus Vulgaris
Fri, 06/8/18 - 10:06 am
Genentech/Roche
Rituxan
pemphigus vulgaris
5 Best-Selling Orphan Drugs in the U.S.
Motley Fool
Wed, 05/30/18 - 09:13 pm
orphan drugs
Celgene
Revlimid
Roche
Rituxan
Teva Pharmaceutical
Copaxone
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
Celltrion resubmits Rituxan candidate in US, Herceptin version to follow
Biopharma Reporter
Wed, 05/30/18 - 08:29 pm
Celltrion
Rituxan
biosimilars
FDA
Herceptin
Roche
Biogen
CT-P10
AbbVie blockbuster leads 2017 top drug sales; Roche cancer meds follow closely
S&P Global
Wed, 03/14/18 - 09:38 pm
AbbVie
Roche
Humira
Rituxan
Herceptin
Avastin
Pfizer’s latest copycat could put the squeeze on Roche — again
Endpoints
Fri, 01/26/18 - 10:57 am
Pfizer
Roche
biosimilars
Rituxan
PF-05280586
Roche CEO Schwan concedes challenges as ‘highly, highly profitable’ drugs fall to biosimilar rivals
Fierce Pharma
Tue, 01/16/18 - 06:56 pm
Roche
Pharma CEOs
Severin Schwan
biosimilars
Herceptin
Rituxan
Avastin
Roche's Fight With Pfizer May Be Just The Beginning
Forbes
Mon, 12/11/17 - 11:31 pm
Roche
Pfizer
Herceptin
biosimilars
cancer
Avastin
Rituxan
Good quarter for Roche, but competition by biosimilars concerns investors
GoinPharma
Mon, 10/23/17 - 11:27 am
Roche
earnings
biosimilars
Rituxan
Roche feeling first effects of biosimilar Rituxan
Biopharma Dive
Thu, 10/19/17 - 06:06 pm
Roche
biosimilars
Rituxan
earnings
AbbVie, Roche to seek broader market for leukemia drug after trial success
BioPharma Dive
Tue, 09/19/17 - 10:23 pm
AbbVie
Roche
clinical trials
Venclexta
Rituxan
chronic lymphocytic leukemia
Poor test results for Roche cloud growth prospects
Yahoo/Reuters
Wed, 07/19/17 - 09:54 am
Roche
biosimilars
Rituxan
Herceptin
Avastin
The biosimilar pack is growing around Roche’s all-star trio, looking to rip into a $21B franchise
Endpoints
Wed, 07/12/17 - 10:36 am
Roche
biosimilars
Avastin
Herceptin
ABP 215
Amgen
MYL-14010
Mylan Labs
Rituxan
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
prescription data
Sanofi
Lantus
Roche
Herceptin
Avastin
Celgene
Revlimid
JNJ
Merck
Remicade
Biogen
Rituxan
Amgen
Enbrel
Gilead Sciences
Harvoni
AbbVie
Humira
Novartis scores second biosimilar approval in two weeks
BioPharma Dive
Thu, 06/29/17 - 09:43 am
Novartis
biosimilars
Enbrel
Europe
Sandoz
Erelzi
Roche
Rituxan
Novartis wins another biosimilar round with an OK for its Rituxan copycat
Endpoints
Mon, 06/19/17 - 03:16 pm
Novartis
biosimilars
Rituxan
Roche
Sandoz
Amid sales growth, Roche plans defense from biosimilar threats
BioPharma Dive
Fri, 04/28/17 - 10:30 am
Roche
biosimilars
Rituxan
Herceptin
Avastin
The 19 Best-Selling Prescription Drugs of All-Time
Motley Fool
Mon, 03/13/17 - 11:29 am
Lipitor
Humira
Seretide
Remicade
Plavix
Enbrel
Rituxan
Herceptin
Avastin
Nexium
Zyprexa
Teva ponies up $160M-plus for marketing rights to Celltrion's Rituxan, Herceptin biosims
Fierce Pharma
Fri, 10/7/16 - 09:11 am
Teva Pharmaceutical
Celltrion
Rituxan
Herceptin
biosimilars
Roche's Hematology Franchise Almost 100% Protected From Biosimilars
Seeking Alpha
Fri, 05/27/16 - 10:59 pm
Roche
hematology
biosimilars
Gazyva
Rituxan

Pages